サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1550123

ノロウイルス診断市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Norovirus Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 245 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
ノロウイルス診断市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年09月05日
発行: Persistence Market Research
ページ情報: 英文 245 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界のノロウイルス診断市場に関する広範なレポートを発行しました。当レポートでは、促進要因・動向・機会・課題などの主要な市場力学を包括的に分析し、市場構造に関する深い洞察を提供しています。

主要な洞察

  • ノロウイルス診断の市場規模（2024年）：6,380万米ドル
  • 市場予測金額（2033年）：1億3,400万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：8.6%

ノロウイルス診断市場 - 調査範囲

ノロウイルス診断市場は、急性胃腸炎の世界の主要原因であるノロウイルス感染を正確に診断するために使用される様々な技術や機器を網羅しています。これらの診断法は、ウイルスをタイムリーかつ正確に検出し、適切な治療を可能にし、アウトブレイクを予防するために不可欠です。同市場は、病院、診断ラボ、POC検査施設など、多様なセグメントにサービスを提供しています。成長の原動力は、ノロウイルス集団感染の増加、診断技術の進歩、さまざまな医療現場での迅速診断検査の適用拡大です。

市場成長の促進要因：

ノロウイルス診断の世界市場を牽引している主要な要因はいくつかあります。ノロウイルス感染症の世界の発生率の上昇は、より多くの患者が正確でタイムリーな診断を必要としているため、市場の成長を後押ししています。迅速抗原検出検査や分子診断法の開発など、診断技術の技術的進歩は、ノロウイルス検出の精度と速度を向上させ、市場拡大をさらに後押ししています。さらに、ノロウイルスに関連する健康リスクに対する意識の高まりや、感染防止対策の実施が増加していることも需要を後押ししています。研究開発の強化と革新的な診断機器の導入は、医療従事者と患者により適したソリューションを提供することで市場拡大に寄与しています。

市場抑制要因：

有望な成長が見込まれるものの、ノロウイルス診断市場は、高度な診断技術にかかる高額なコストや、偽陰性結果に伴う潜在的なリスクに関連する課題に直面しています。症状に基づく臨床診断のような代替診断ソリューションが利用可能であるため、市場の成長が妨げられる可能性があります。さらに、低資源環境における高度な診断法へのアクセスに関する懸念は、市場拡大の課題となっています。これらの問題に対処するためには、ノロウイルス診断の精度、価格、利用しやすさを向上させるための研究開発への継続的な投資が必要です。

市場機会：

この市場は、ノロウイルス検出の精度と迅速性を向上させる分子診断薬や迅速抗原検出検査の採用拡大が大きなビジネスチャンスとなっています。マルチプレックスアッセイや次世代シーケンシングなどの高度な診断技術の開発は、より正確で包括的な診断オプションに対するニーズの高まりに対応しています。新興市場におけるヘルスケア・インフラの拡大は、市場成長のための新たなチャネルを提供し、企業はより広範な患者集団にリーチし、最先端の診断法へのアクセスを提供することができます。戦略的パートナーシップ、ヘルスケア専門家向けのトレーニングプログラムへの投資、患者中心のアプローチの採用は、新たなビジネスチャンスを生かし、市場でのリーダーシップを維持するために不可欠です。

本レポートで扱う主要な質問

  • 世界のノロウイルス診断市場の成長を促進する主要な要因は何か？
  • 様々なヘルスケア環境において、どのようなノロウイルス診断の種類と技術が採用をリードしているか？
  • 技術の進歩はノロウイルス診断市場の競合情勢にどのような影響を与えているか？
  • ノロウイルス診断市場の主要企業はどこで、競争力を維持するためにどのような戦略を採用しているのか？
  • 世界のノロウイルス診断市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 製品採用分析
  • 主要な規制
  • 最近の製品の発売 / 承認
  • PESTEL分析
  • 主要なプロモーション戦略：主要企業別
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 2022年の市場シナリオ

第7章 世界のノロウイルス診断市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界のノロウイルス診断市場分析、製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析、製品別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測、製品別、2024年～2033年
    • 迅速検査キット
    • PCRキット
    • ELISAベースキット
  • 市場の魅力分析：製品別

第9章 世界のノロウイルス診断市場分析、エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分析、エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測、エンドユーザー別、2024年～2033年
    • 病院
    • 診断ラボ
    • クリニック
  • 市場の魅力分析：エンドユーザー別

第10章 世界のノロウイルス診断市場分析、地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）の分析、地域別、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）の分析と予測、地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第11章 北米のノロウイルス診断市場分析

第12章 ラテンアメリカのノロウイルス診断市場分析

第13章 欧州のノロウイルス診断市場分析

第14章 東アジアのノロウイルス診断市場分析

第15章 南アジアのノロウイルス診断市場分析

第16章 オセアニアのノロウイルス診断市場

第17章 中東・アフリカ（MEA）のノロウイルス診断市場分析

第18章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • 競合の詳細情報
    • Abbott
    • R-Biopharm AG
    • Cepheid
    • Luminex Corporation
    • Meridian Bioscience
    • ELITechGroup
    • Biomerieux SA
    • CerTest Biotec SL
    • Elisabeth Pharmacon, Spol. S Ro
    • Qiagen
    • Altona Diagnostics GmbH
    • Eiken Chemical Co

第20章 使用される前提条件と頭字語

第21章 調査手法

目次
Product Code: PMRREP25924

Persistence Market Research has recently published an extensive report on the global Norovirus Diagnostics Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Norovirus Diagnostics Market Size (2024E): USD 63.8 Million
  • Projected Market Value (2033F): USD 134 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 8.6%

Norovirus Diagnostics Market - Report Scope:

The Norovirus Diagnostics Market encompasses a variety of techniques and devices used to accurately diagnose norovirus infections, which are a leading cause of acute gastroenteritis globally. These diagnostic methods are critical for ensuring timely and accurate detection of the virus, enabling appropriate treatment and preventing outbreaks. The market serves diverse segments, including hospitals, diagnostic laboratories, and point-of-care testing facilities. Growth is driven by the increasing incidence of norovirus outbreaks, advancements in diagnostic technologies, and the expanding application of rapid diagnostic tests across various healthcare settings.

Market Growth Drivers:

Several key factors are driving the global Norovirus Diagnostics Market. The rising incidence of norovirus infections globally boosts the market's growth as more patients require accurate and timely diagnosis. Technological advancements in diagnostic techniques, such as the development of rapid antigen detection tests and molecular diagnostics, have improved the precision and speed of norovirus detection, further fueling market expansion. Additionally, the growing awareness of norovirus-related health risks and the increasing implementation of infection control measures drive demand. Enhanced research and development activities, along with the introduction of innovative diagnostic devices, contribute to market growth by offering more tailored solutions for healthcare providers and patients.

Market Restraints:

Despite promising growth prospects, the Norovirus Diagnostics Market faces challenges related to the high costs of advanced diagnostic techniques and the potential risks associated with false-negative results. Market growth can be hindered by the availability of alternative diagnostic solutions, such as clinical diagnosis based on symptoms, which may be preferred by some healthcare providers due to their simplicity. Additionally, concerns about the accessibility of advanced diagnostic methods in low-resource settings pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve the accuracy, affordability, and accessibility of norovirus diagnostics.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of molecular diagnostics and rapid antigen detection tests, which offer improved accuracy and speed in norovirus detection. The development of advanced diagnostic technologies, such as multiplex assays and next-generation sequencing, caters to the growing need for more precise and comprehensive diagnostic options. The expansion of healthcare infrastructure in emerging markets provides new channels for market growth, allowing companies to reach a broader patient population and offer access to cutting-edge diagnostic methods. Strategic partnerships, investments in training programs for healthcare professionals, and the introduction of patient-centered approaches are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Norovirus Diagnostics Market globally?
  • Which types and techniques of norovirus diagnostics are leading the adoption in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the Norovirus Diagnostics Market?
  • Who are the key players in the Norovirus Diagnostics Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Norovirus Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Norovirus Diagnostics Market, including BioMerieux SA, DiaSorin S.p.A., and Luminex Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions and explore new detection technologies. Collaborations with healthcare providers, research institutions, and technology developers facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive training programs fosters market growth and enhances brand loyalty in the evolving Norovirus Diagnostics Market landscape.

Key Companies Profiled:

  • Abbott
  • R-Biopharm AG
  • Cepheid
  • Luminex Corporation
  • Meridian Bioscience
  • ELITechGroup
  • Biomerieux SA
  • CerTest Biotec S.L.
  • Elisabeth Pharmacon, Spol. S Ro
  • Qiagen
  • Altona Diagnostics GmbH
  • Eiken Chemical Co

Norovirus Diagnostics Market Industry Segmentation

By Product

  • Rapid Test Kits
  • PCR Kits
  • ELISA based kits

By End-User

  • Hospitals
  • Diagnostics Labs
  • Clinics

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Key Regulations
  • 4.3. Recent Product launches/ Approvals
  • 4.4. PESTEL Analysis
  • 4.5. Key Promotional Strategies, By Key Players
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Viral Testing Diagnostic Kits Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising prevalence of Norovirus
    • 5.2.2. Increasing Demand for Rapid Testing
    • 5.2.3. Technological Advancement
    • 5.2.4. Awareness and growing government funding
    • 5.2.5. Rising initiatives by public and private organizations
    • 5.2.6. Growth of Norovirus Diagnostics Centers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By End User
    • 6.1.3. By Country
  • 6.2. 2022 Market Scenario

7. Global Norovirus Diagnostics Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Rapid Test Kits
    • 8.3.2. PCR Kits
    • 8.3.3. ELISA based kits
  • 8.4. Market Attractiveness Analysis By Product

9. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostics laboratories
    • 9.3.3. Clinics
  • 9.4. Market Attractiveness Analysis By End User

10. Global Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By End User
  • 11.5. Market Trends
  • 11.6. Drivers and Restraints - Impact Analysis
  • 11.7. Key Players - Intensity Mapping
  • 11.8. Country Level Analysis & Forecast
    • 11.8.1. U.S. Norovirus Diagnostics Market Analysis
      • 11.8.1.1. Introduction
      • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.1.2.1. By Product
        • 11.8.1.2.2. By End User
    • 11.8.2. Canada Norovirus Diagnostics Market Analysis
      • 11.8.2.1. Introduction
      • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.8.2.2.1. By Product
        • 11.8.2.2.2. By End User

12. Latin America Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Mexico
      • 12.3.1.2. Brazil
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By End User
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. Mexico Norovirus Diagnostics Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By End User
    • 12.8.2. Brazil Norovirus Diagnostics Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By End User
    • 12.8.3. Argentina Norovirus Diagnostics Market Analysis
      • 12.8.3.1. Introduction
      • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.3.2.1. By Product
        • 12.8.3.2.2. By End User

13. Europe Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Germany Norovirus Diagnostics Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By End User
    • 13.8.2. Italy Norovirus Diagnostics Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By End User
    • 13.8.3. France Norovirus Diagnostics Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By End User
    • 13.8.4. U.K. Norovirus Diagnostics Market Analysis
      • 13.8.4.1. Introduction
      • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.4.2.1. By Product
        • 13.8.4.2.2. By End User
    • 13.8.5. Spain Norovirus Diagnostics Market Analysis
      • 13.8.5.1. Introduction
      • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.5.2.1. By Product
        • 13.8.5.2.2. By End User
    • 13.8.6. BENELUX Norovirus Diagnostics Market Analysis
      • 13.8.6.1. Introduction
      • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.6.2.1. By Product
        • 13.8.6.2.2. By End User
    • 13.8.7. Russia Norovirus Diagnostics Market Analysis
      • 13.8.7.1. Introduction
      • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.7.2.1. By Product
        • 13.8.7.2.2. By End User

14. East Asia Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Norovirus Diagnostics Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By End User
    • 14.8.2. Japan Norovirus Diagnostics Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By End User
    • 14.8.3. South Korea Norovirus Diagnostics Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By End User

15. South Asia Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Malaysia
      • 15.3.1.4. Thailand
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Norovirus Diagnostics Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By End User
    • 15.8.2. Indonesia Norovirus Diagnostics Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By End User
    • 15.8.3. Malaysia Norovirus Diagnostics Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By End User
    • 15.8.4. Thailand Norovirus Diagnostics Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By End User

16. Oceania Norovirus Diagnostics Market 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Australia Norovirus Diagnostics Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By End User
    • 16.8.2. New Zealand Norovirus Diagnostics Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By End User

17. Middle East and Africa (MEA) Norovirus Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkey
      • 17.3.1.3. North Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. GCC Countries Norovirus Diagnostics Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By End User
    • 17.8.2. Turkey Norovirus Diagnostics Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By End User
    • 17.8.3. South Africa Norovirus Diagnostics Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By End User
    • 17.8.4. North Africa Norovirus Diagnostics Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By End User

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Abbott
      • 19.2.1.1. Overview
      • 19.2.1.2. Product Portfolio
      • 19.2.1.3. Sales Footprint
      • 19.2.1.4. Key Financials
      • 19.2.1.5. SWOT Analysis
      • 19.2.1.6. Strategy Overview
        • 19.2.1.6.1. Marketing Strategy
        • 19.2.1.6.2. Product Strategy
        • 19.2.1.6.3. Channel Strategy
    • 19.2.2. R-Biopharm AG
      • 19.2.2.1. Overview
      • 19.2.2.2. Product Portfolio
      • 19.2.2.3. Sales Footprint
      • 19.2.2.4. Key Financials
      • 19.2.2.5. SWOT Analysis
      • 19.2.2.6. Strategy Overview
        • 19.2.2.6.1. Marketing Strategy
        • 19.2.2.6.2. Product Strategy
        • 19.2.2.6.3. Channel Strategy
    • 19.2.3. Cepheid
      • 19.2.3.1. Overview
      • 19.2.3.2. Product Portfolio
      • 19.2.3.3. Sales Footprint
      • 19.2.3.4. Key Financials
      • 19.2.3.5. SWOT Analysis
      • 19.2.3.6. Strategy Overview
        • 19.2.3.6.1. Marketing Strategy
        • 19.2.3.6.2. Product Strategy
        • 19.2.3.6.3. Channel Strategy
    • 19.2.4. Luminex Corporation
      • 19.2.4.1. Overview
      • 19.2.4.2. Product Portfolio
      • 19.2.4.3. Sales Footprint
      • 19.2.4.4. Key Financials
      • 19.2.4.5. SWOT Analysis
      • 19.2.4.6. Strategy Overview
        • 19.2.4.6.1. Marketing Strategy
        • 19.2.4.6.2. Product Strategy
        • 19.2.4.6.3. Channel Strategy
    • 19.2.5. Meridian Bioscience
      • 19.2.5.1. Overview
      • 19.2.5.2. Product Portfolio
      • 19.2.5.3. Sales Footprint
      • 19.2.5.4. Key Financials
      • 19.2.5.5. SWOT Analysis
      • 19.2.5.6. Strategy Overview
        • 19.2.5.6.1. Marketing Strategy
        • 19.2.5.6.2. Product Strategy
        • 19.2.5.6.3. Channel Strategy
    • 19.2.6. ELITechGroup
      • 19.2.6.1. Overview
      • 19.2.6.2. Product Portfolio
      • 19.2.6.3. Sales Footprint
      • 19.2.6.4. Key Financials
      • 19.2.6.5. SWOT Analysis
      • 19.2.6.6. Strategy Overview
        • 19.2.6.6.1. Marketing Strategy
        • 19.2.6.6.2. Product Strategy
        • 19.2.6.6.3. Channel Strategy
    • 19.2.7. Biomerieux SA
      • 19.2.7.1. Overview
      • 19.2.7.2. Product Portfolio
      • 19.2.7.3. Sales Footprint
      • 19.2.7.4. Key Financials
      • 19.2.7.5. SWOT Analysis
      • 19.2.7.6. Strategy Overview
        • 19.2.7.6.1. Marketing Strategy
        • 19.2.7.6.2. Product Strategy
        • 19.2.7.6.3. Channel Strategy
    • 19.2.8. CerTest Biotec S.L.
      • 19.2.8.1. Overview
      • 19.2.8.2. Product Portfolio
      • 19.2.8.3. Sales Footprint
      • 19.2.8.4. Key Financials
      • 19.2.8.5. SWOT Analysis
      • 19.2.8.6. Strategy Overview
        • 19.2.8.6.1. Marketing Strategy
        • 19.2.8.6.2. Product Strategy
        • 19.2.8.6.3. Channel Strategy
    • 19.2.9. Elisabeth Pharmacon, Spol. S Ro
      • 19.2.9.1. Overview
      • 19.2.9.2. Product Portfolio
      • 19.2.9.3. Sales Footprint
      • 19.2.9.4. Key Financials
      • 19.2.9.5. SWOT Analysis
      • 19.2.9.6. Strategy Overview
        • 19.2.9.6.1. Marketing Strategy
        • 19.2.9.6.2. Product Strategy
        • 19.2.9.6.3. Channel Strategy
    • 19.2.10. Qiagen
      • 19.2.10.1. Overview
      • 19.2.10.2. Product Portfolio
      • 19.2.10.3. Sales Footprint
      • 19.2.10.4. Key Financials
      • 19.2.10.5. SWOT Analysis
      • 19.2.10.6. Strategy Overview
        • 19.2.10.6.1. Marketing Strategy
        • 19.2.10.6.2. Product Strategy
        • 19.2.10.6.3. Channel Strategy
    • 19.2.11. Altona Diagnostics GmbH
      • 19.2.11.1. Overview
      • 19.2.11.2. Product Portfolio
      • 19.2.11.3. Sales Footprint
      • 19.2.11.4. Key Financials
      • 19.2.11.5. SWOT Analysis
      • 19.2.11.6. Strategy Overview
        • 19.2.11.6.1. Marketing Strategy
        • 19.2.11.6.2. Product Strategy
        • 19.2.11.6.3. Channel Strategy
    • 19.2.12. Eiken Chemical Co
      • 19.2.12.1. Overview
      • 19.2.12.2. Product Portfolio
      • 19.2.12.3. Sales Footprint
      • 19.2.12.4. Key Financials
      • 19.2.12.5. SWOT Analysis
      • 19.2.12.6. Strategy Overview
        • 19.2.12.6.1. Marketing Strategy
        • 19.2.12.6.2. Product Strategy
        • 19.2.12.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology